|
GB725228A
(en)
|
1952-06-19 |
1955-03-02 |
Roche Products Ltd |
Substituted carbamic acid esters and process for the manufacture thereof
|
|
BE640616A
(pl)
|
1962-12-19 |
|
|
|
|
NL130759C
(pl)
|
1965-10-07 |
|
|
|
|
US3492397A
(en)
|
1967-04-07 |
1970-01-27 |
Warner Lambert Pharmaceutical |
Sustained release dosage in the pellet form and process thereof
|
|
US4060598A
(en)
|
1967-06-28 |
1977-11-29 |
Boehringer Mannheim G.M.B.H. |
Tablets coated with aqueous resin dispersions
|
|
US3538214A
(en)
|
1969-04-22 |
1970-11-03 |
Merck & Co Inc |
Controlled release medicinal tablets
|
|
US4173626A
(en)
|
1978-12-11 |
1979-11-06 |
Merck & Co., Inc. |
Sustained release indomethacin
|
|
US4593034A
(en)
|
1984-04-06 |
1986-06-03 |
A. H. Robins Company, Inc. |
2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
IE62231B1
(en)
|
1987-12-24 |
1995-01-11 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
|
ATE85217T1
(de)
|
1988-08-04 |
1993-02-15 |
Synthelabo |
Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.>oct-3-yl)benzamide und thiobenzamide.
|
|
US5549892A
(en)
|
1988-12-23 |
1996-08-27 |
Genzyme Corporation |
Enhanced in vivo uptake of glucocerebrosidase
|
|
US5236838A
(en)
|
1988-12-23 |
1993-08-17 |
Genzyme Corporation |
Enzymatically active recombinant glucocerebrosidase
|
|
IT1228293B
(it)
|
1989-02-06 |
1991-06-07 |
Angeli Inst Spa |
Benzoderivati di composti eterociclici contenenti azoto.
|
|
DK443489D0
(da)
|
1989-09-08 |
1989-09-08 |
Ferrosan As |
Substituerede urinstofforbindelser, deres fremstilling og anvendelse
|
|
US5272071A
(en)
|
1989-12-22 |
1993-12-21 |
Applied Research Systems Ars Holding N.V. |
Method for the modification of the expression characteristics of an endogenous gene of a given cell line
|
|
GB9106571D0
(en)
|
1991-03-27 |
1991-05-15 |
Erba Carlo Spa |
Derivatives of substituted imidazol-2-one and process for their preparation
|
|
US5733761A
(en)
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
DE4326510A1
(de)
|
1993-08-06 |
1995-02-09 |
Bayer Ag |
Verfahren zur Herstellung von Cyclohexen-Derivaten
|
|
HUT76289A
(en)
|
1994-02-10 |
1997-07-28 |
Yamanouchi Pharma Co Ltd |
Carbamate derivative and medicinal composition containing the same
|
|
JPH08198751A
(ja)
|
1995-01-19 |
1996-08-06 |
Yamanouchi Pharmaceut Co Ltd |
カルバメート誘導体
|
|
AU7551896A
(en)
|
1995-11-08 |
1997-05-29 |
American Home Products Corporation |
1-azabicycloheptane derivatives and their pharmaceutical use
|
|
SE9600683D0
(sv)
|
1996-02-23 |
1996-02-23 |
Astra Ab |
Azabicyclic esters of carbamic acids useful in therapy
|
|
EP0923536A1
(en)
|
1996-07-29 |
1999-06-23 |
Pharmacia & Upjohn Aktiebolag |
Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
|
|
JP2002522509A
(ja)
|
1997-10-29 |
2002-07-23 |
ジェンザイム・コーポレイション |
リソソーム貯蔵疾患治療組成物および方法
|
|
US5985836A
(en)
|
1998-07-31 |
1999-11-16 |
Bayer Corporation |
Alpha-1 proteinase inhibitor binding peptides
|
|
KR20010100965A
(ko)
|
1998-11-02 |
2001-11-14 |
가마꾸라 아끼오 |
피롤리딘 화합물 및 이것의 의약 용도
|
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
EP1165542B1
(en)
|
1999-03-29 |
2003-08-20 |
Neurogen Corporation |
4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
|
|
FR2791678B1
(fr)
|
1999-03-30 |
2001-05-04 |
Synthelabo |
Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
|
|
KR20020084116A
(ko)
|
2000-02-07 |
2002-11-04 |
애보트 게엠베하 운트 콤파니 카게 |
2-벤조티아졸릴 우레아 유도체 및 이의 단백질 키나제억제제로서의 용도
|
|
GB0010955D0
(en)
|
2000-05-05 |
2000-06-28 |
Novartis Ag |
Organic compounds
|
|
US6916828B2
(en)
|
2000-06-27 |
2005-07-12 |
Laboratorios S.A.L.V.A.T., S.A. |
Carbamates derivatived from arylakylamines
|
|
ATE480155T1
(de)
|
2000-07-19 |
2010-09-15 |
Unitika Ltd |
Physiologisch wirksame lebensmittel sowie kosmetika enthaltend sphingoglycolipide aus konjac für die verbesserung der feuchtigkeit und rauheit der haut
|
|
WO2002016356A2
(en)
|
2000-08-18 |
2002-02-28 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
|
|
WO2002015662A2
(en)
|
2000-08-21 |
2002-02-28 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
|
|
RU2296762C2
(ru)
|
2000-12-22 |
2007-04-10 |
Альмиралль Продесфарма Аг |
Карбаматы хинуклидина, способы их получения и фармацевтическая композиция на их основе
|
|
EP1231212B1
(en)
|
2001-02-06 |
2006-12-20 |
Pfizer Products Inc. |
Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders
|
|
JP2003267977A
(ja)
|
2002-03-14 |
2003-09-25 |
Yamanouchi Pharmaceut Co Ltd |
キヌクリジン誘導体
|
|
DE10211415A1
(de)
|
2002-03-15 |
2003-09-25 |
Bayer Ag |
Bicyclische N-Biarylamide
|
|
ES2203327B1
(es)
|
2002-06-21 |
2005-06-16 |
Almirall Prodesfarma, S.A. |
Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
CA2492404C
(en)
|
2002-07-17 |
2012-02-07 |
Oxford Glycosciences (Uk) Ltd |
Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
|
|
WO2004011430A1
(ja)
|
2002-07-25 |
2004-02-05 |
Yamanouchi Pharmaceutical Co., Ltd. |
ナトリウムチャネル阻害剤
|
|
SE0202430D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New Compounds
|
|
DK1949901T3
(da)
|
2002-12-06 |
2014-05-19 |
The Feinstein Inst Medical Res |
Fremgangsmåde til bestemmelse af en cholinerg agonist selektiv for en alfa-7-nikotinsk receptor
|
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
US20050031683A1
(en)
|
2003-08-04 |
2005-02-10 |
Ashish Kapoor |
Solid pharmaceutical composition
|
|
TW200529860A
(en)
|
2003-12-22 |
2005-09-16 |
Astrazeneca Ab |
Nicotinic acetylcholine receptor ligands
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
JP2007186422A
(ja)
|
2004-01-28 |
2007-07-26 |
Astellas Pharma Inc |
アリールスルフィド誘導体
|
|
CA2571584A1
(en)
|
2004-06-23 |
2006-01-05 |
The Feinstein Institute For Medical Research |
Method of treating ileus by pharmacological activation of cholinergic receptors
|
|
US8003617B2
(en)
|
2004-11-10 |
2011-08-23 |
Genzyme Corporation |
Methods of treating diabetes mellitus
|
|
US20090131470A1
(en)
|
2005-06-11 |
2009-05-21 |
Vernalis R & D Limited |
Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
|
|
AU2006295397A1
(en)
|
2005-09-23 |
2007-04-05 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
SG131819A1
(en)
|
2005-11-07 |
2007-05-28 |
Chikka Pte Ltd |
Buddy-based cross-carrier messaging system
|
|
KR20070077468A
(ko)
|
2006-01-23 |
2007-07-26 |
크리스탈지노믹스(주) |
단백질 키나아제 활성을 저해하는 이미다조피리딘 유도체,이의 제조방법 및 이를 함유하는 약학 조성물
|
|
US20090318491A1
(en)
|
2006-01-27 |
2009-12-24 |
Yale Univeristy |
Cytisine and Acetylcholine Analogs and Methods of Treating Mood Disorders
|
|
US7840109B2
(en)
|
2006-08-14 |
2010-11-23 |
Adc Telecommunications, Inc. |
Factory spliced cable assembly
|
|
BRPI0806972A2
(pt)
|
2007-02-09 |
2014-04-08 |
Astellas Pharma Inc |
Composto cíclico contendo ponte azo
|
|
US8178551B2
(en)
|
2007-03-09 |
2012-05-15 |
Green Cross Corporation |
Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson'S disease prevention or treatment
|
|
WO2008121826A2
(en)
|
2007-03-30 |
2008-10-09 |
Amicus Therapeutics, Inc. |
Method for the treatment of fabry disease using pharmacological chaperones
|
|
AU2008266960A1
(en)
|
2007-06-20 |
2008-12-24 |
Merck Sharp & Dohme Corp. |
Diphenyl substituted alkanes
|
|
EP2211856A4
(en)
|
2007-11-29 |
2011-02-09 |
Hospital For Sick Children |
COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDER
|
|
JP2011529500A
(ja)
|
2008-07-28 |
2011-12-08 |
ジェンザイム コーポレーション |
虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害
|
|
EP2154136A1
(en)
|
2008-08-08 |
2010-02-17 |
CHIESI FARMACEUTICI S.p.A. |
Quinuclidine carbonate derivatives and medicinal compositions thereof
|
|
WO2010091164A1
(en)
|
2009-02-06 |
2010-08-12 |
Exelixis, Inc. |
Inhibitors of glucosylceramide synthase
|
|
WO2010091104A1
(en)
|
2009-02-06 |
2010-08-12 |
Exelixis, Inc. |
Glucosylceramide synthase inhibitors
|
|
US8993556B2
(en)
|
2009-04-21 |
2015-03-31 |
Nerviano Medical Sciences S.R.L. |
Resorcinol derivatives as HSP90 inhibitors
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
US20120157464A1
(en)
|
2009-07-23 |
2012-06-21 |
Novartis Ag |
Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives for the treatment or prevention of ataxia
|
|
CN106047835A
(zh)
|
2009-08-28 |
2016-10-26 |
西奈山医学院 |
用于治疗酸性鞘磷脂酶缺乏的剂量递增酶替代疗法
|
|
US20110183938A1
(en)
|
2009-12-16 |
2011-07-28 |
Genentech, Inc. |
1,7-diazacarbazoles and methods of use
|
|
WO2011141483A2
(en)
|
2010-05-10 |
2011-11-17 |
Laboratorios Lesvi, S.L. |
Stable pharmaceutical formulations containing an antihistaminic
|
|
RU2436782C1
(ru)
|
2010-06-10 |
2011-12-20 |
Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) |
2-МЕТОКСИ-4[(3aR,7aS)-3,3,6-ТРИМЕТИЛ-1,3,3a,4,5,7a-ГЕКСАГИДРО-2-БЕНЗОФУРАН-1-ИЛ]ФЕНОЛ - НОВОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ ПАРКИНСОНА
|
|
RU2607084C2
(ru)
|
2010-11-12 |
2017-01-10 |
Сионоги Энд Ко., Лтд. |
Кристаллы производных 6,7-ненасыщенного-7-карбамоилморфинана и способ их получения
|
|
CN103917094B
(zh)
|
2011-03-18 |
2016-11-09 |
建新公司 |
葡萄糖基神经酰胺合酶抑制剂
|
|
EP2723384B1
(en)
|
2011-06-22 |
2018-08-29 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
EP2723734A1
(en)
|
2011-06-22 |
2014-04-30 |
Isochem |
Process for the preparation of solifenacin and salts thereof
|
|
JOP20130273B1
(ar)
*
|
2012-09-11 |
2021-08-17 |
Genzyme Corp |
مثبطات انزيم (سينثاز) غلوكوسيل سيراميد
|
|
DK2895187T1
(da)
|
2012-09-11 |
2015-11-16 |
Hospira Australia Pty Ltd |
Daptomycinformuleringer og anvendelser deraf
|
|
JO3713B1
(ar)
|
2013-03-15 |
2021-01-31 |
Genzyme Corp |
أشكال ملح (s)-كوينوكليدين-3-يل(2-(2-(4-فلوروفينيل)ثيازول-4-يل)بروبان-2-يل)كارباميت
|
|
KR20150130386A
(ko)
|
2013-03-15 |
2015-11-23 |
젠자임 코포레이션 |
글루코실세라마이드 신타아제 저해제의 제조 방법
|
|
CN105979945A
(zh)
|
2013-12-11 |
2016-09-28 |
建新公司 |
葡糖神经酰胺合酶抑制剂
|
|
TW201642855A
(zh)
*
|
2015-03-10 |
2016-12-16 |
健臻公司 |
用於治療蛋白質病變之方法
|
|
WO2017087409A1
(en)
*
|
2015-11-18 |
2017-05-26 |
Genzyme Corporation |
Biomarker of polycystic kidney disease and uses thereof
|
|
WO2017135753A1
(ko)
|
2016-02-05 |
2017-08-10 |
경북대학교 산학협력단 |
혈관내피성장인자를 과발현한 줄기세포를 유효성분으로 포함하는 퇴행성 신경질환의 예방 또는 치료용 약학적 조성물
|
|
WO2017192841A1
(en)
|
2016-05-04 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
EP3318277A1
(en)
|
2016-11-04 |
2018-05-09 |
Institut du Cerveau et de la Moelle Epiniere-ICM |
Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases
|
|
US10588888B2
(en)
|
2017-07-17 |
2020-03-17 |
Children's Hospital Medical Center |
CNS-accessible pharmacological chaperones for treatment of acid β-glucosidase-related disease states
|
|
US12472144B2
(en)
|
2017-08-08 |
2025-11-18 |
Amneal Pharmaceuticals Llc |
Pharmaceutical composition comprising eliglustat
|
|
US10519157B2
(en)
|
2018-02-09 |
2019-12-31 |
X-Cutag Therapeutics, Inc. |
Deuterated compounds for treating Fabry, Gaucher, Parkinson's and related diseases and conditions, and compositions and methods thereof
|
|
PL3920912T3
(pl)
|
2019-02-04 |
2025-11-12 |
Genzyme Corporation |
Leczenie ciliopatii przy użyciu inhibitorów syntazy glukozyloceramidowej (gcs)
|
|
US12357624B2
(en)
|
2019-02-04 |
2025-07-15 |
Prilenia Neurotherapeutics Ltd. |
Low dose pridopidine for Parkinson's Disease and other diseases associated with parkinsonism
|
|
CN113710249A
(zh)
|
2019-02-04 |
2021-11-26 |
建新公司 |
用于治疗溶酶体贮积症相关的症状和病症的方法
|
|
US20220411371A1
(en)
|
2019-09-25 |
2022-12-29 |
Teva Pharmaceuticals International Gmbh |
Solid state forms of lucerastat and process for preparation thereof
|
|
AU2021215396B2
(en)
|
2020-02-03 |
2026-02-19 |
Genzyme Corporation |
Methods for treating neurological symptoms associated with lysosomal storage diseases
|
|
US11857512B2
(en)
|
2020-07-24 |
2024-01-02 |
Genzyme Corporation |
Pharmaceutical compositions comprising venglustat
|
|
BR112023001362A2
(pt)
|
2020-07-30 |
2023-02-14 |
Genzyme Corp |
Métodos para redução da concentração de glicoesfingolipídio no tecido cerebral e métodos de tratamento doenças neurodegenerativas envolvendo os mesmos
|